Amador Bioscience strives to provide global-standard laboratory, clinical research, strategy consulting and regulatory filing services to biopharmaceutical companies. The laboratory services focus Ｏn PK/PD/ADA assay development and sample analysis. Amador clinical research unit specializes in innovative clinical development strategy and protocol design, and initiation and monitoring of clinical studies in China and US. In addition to R&D strategy and regulatory pathway, our consulting services perform global-standard data analysis and generate submission-ready study reports. We have successfully supported CTD filings in China and US.
With profound academic background and rich experience in R&D services in the biopharmaceutical industry, AmadorBio is a global clinical research team of pharmacologists, statisticians, bioanalytical scientists, translational & clinical scientists, medical scientists, clinical trial management experts, data management experts, quality assurance auditors, clinical trial managers and regulatory specialists. (40% of PhD, MD and PharmD, 35% of MS). AmadorBio provides professional services for more than 20 leading biopharmaceutical companies from early research and development, clinical development to regulatory submission in China and US.
AmadorBio operates in biotech hubs: San Francisco Bay Area, USA and Shanghai-Hangzhou-Suzhou region, China, providing comprehensive solutions complied with global standards and government drug inspection regulations in China and US.
The mission of Amador is to provide global-standard services facilitating the development of novel biotherapeutics.
安渡生物致力于为生物医药公司提供全球标准的实验室、临床研究、策略咨询和监管申报服务。实验室服务专注于PK/PD/ADA方法学开发验证和样本分析。安渡生物的临床研究中心专注于为美国和中国的生物医药公司提供创新的临床研究开发策略、方案设计、启动和监查的专业服务。我们的咨询服务除研发策略和监管服务外，还可提供全球标准的数据分析并生成完备的申请报告。我们在中国和美国成功地支持了多家医药公司的CTD申请。
安渡生物在美国旧金山湾区和中国长三角地区设有办公室和实验室，提供涵盖中美及符合国际标准和政府药检规范的全方位解决方案。
旧金山
关注微信公众号
随时随地接受微信通知
手机WAP浏览
微信公众号
陕公网安备61011202000767
关注
